TRC160334
TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334 can be used for the research of ischemia/reperfusion injury[1].
Product Specifications
CAS Number
1293289-69-6
UNSPSC
12352005
Target
HIF/HIF Prolyl-Hydroxylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/trc160334.html
Concentration
10mM
Purity
98.22
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(C1=C(O)N=C(SC2=C3CCCCC2)N3C1=O)NCC(O)=O
Molecular Formula
C14H15N3O5S
Molecular Weight
337.35
References & Citations
[1]Jamadarkhana P, et al. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury. Am J Nephrol. 2012;36 (3) :208-218.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY432254 100 µg
ZNF312B (FEZF1) (NM_001024613) Human Over-expression Lysate
Sign In for Pricing
View Details 